XMax Prelim Q3: Sales Fall to $6.42M, Net Loss $12.1M-$13.1M on Non-Cash Unrealized Loss
XMAX sits 40% above its 52-week low of $3.03 on elevated volume (3.7× avg).
Summary
XMax reported preliminary Q3 2026 net sales of about $6.42 million, down from $9.76 million a year ago, and a net loss of $12.10 million to $13.10 million driven mainly by a non-cash unrealized loss on investments.
Key Events · Earnings and Guidance · XMAX
-
Q3 Sales Drop 34% Year Over Year
Preliminary Q3 2026 net sales were approximately $6.42 million versus $9.76 million in Q3 2025; nine-month sales were approximately $10.94 million versus $14.95 million.
-
Net Loss Driven by Non-Cash Mark
Q3 2026 net loss is expected at $12.10 million to $13.10 million, primarily a non-cash unrealized loss on investments — not a cash outflow and not new dilution. Nine-month net income of $19.50 million to $20.50 million is likewise mostly a non-cash unrealized gain.
-
Gross Margin Improves to 13.9%
Q3 2026 gross profit was approximately $0.89 million at a 13.9% margin, up from 10.1% a year earlier, even as sales volume fell.
-
10-Q Due by November 16, 2026
Figures are preliminary and unreviewed by the auditor; final results will be reported in the Form 10-Q expected on or before November 16, 2026.
Analysis · XMAX · Manufacturing
XMax's furniture distribution business is shrinking fast: quarterly net sales fell to about $6.42 million from $9.76 million a year earlier, a roughly 34% decline. Yet the reported bottom line is dominated by swings in the value of its investment portfolio rather than operations. The Q3 net loss of $12.10 million to $13.10 million is described as primarily a non-cash unrealized loss, meaning it reflects mark-to-market marks on investments, not cash leaving the business; the nine-month net income of $19.50 million to $20.50 million is likewise mostly a non-cash unrealized gain. That matters because the company is simultaneously asking shareholders to authorize up to $170 million in discounted stock sales to cure a Nasdaq Rule 5635(d) deficiency, and a widening operating loss makes that capital raise more necessary. These are preliminary, unreviewed figures; the full 10-Q is due on or before November 16, 2026.
How filings like this one have moved
In the 30 days to Nov 4, 2026, 32.4% of the 2240 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, XMAX was trading at $4.25 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $272.2M. The 52-week trading range was $3.03 to $9.40. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.